(Q46524645)

English

Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis

scientific article published in June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

1 reference

based on heuristic

inferred from title

author name string

T Ohkusa

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

T Maekawa

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

T Arakawa

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

M Nakajima

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

K Fujimoto

5

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

E Hoshino

6

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

Y Mitachi

7

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

S Hamada

8

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

T Mine

9

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

Y Kawahara

10

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

T Nagai

11

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

N Aoyama

12

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

N Yoshida

13

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

K Tadokoro

14

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

N Chida

15

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

Y Konda

16

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

H Seno

17

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

T Shimatani

18

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

M Inoue

19

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

N Sato

20

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

21

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

1331-1339

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

11

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02486.X

21 January 2018

Review article: long-term use of proton pump inhibitors in GORD--help or hindrance?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02486.X

21 January 2018

Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02486.X

21 January 2018

Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02486.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2005.02486.X

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15932363

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46524645&oldid=2116174434"